건염 치료 시장 보고서(2025년)
Tendonitis Treatment Global Market Report 2025
상품코드 : 1824314
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 건염 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 5.1%로 확대되어 2,778억 9,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 정부의 지원과 자금 제공, 맞춤형 의료, 재생 요법의 확대, 비침습적 치료에 대한 수요 증가, 원격 모니터링, 원격 의료로 인한 것으로 예측됩니다. 예측기간의 주요 동향으로는 연구개발, 재생요법, 물리치료의 진보, 저침습치료에 대한 주력, 원격진찰을 위한 원격의료 등이 있습니다.

향후 5년간의 성장률 5.1%라는 예측은 지난 예측으로부터 0.2% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 아일랜드와 일본에서 조달하는 초음파 유도 부신 피질 스테로이드 주사 키트의 비용을 상승시키고 통증 관리를 지연시키고 정형외과 클리닉의 비용을 상승시킴으로써 미국에 지장을 초래할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

스포츠 부상 증가는 향후 건염 치료 시장의 성장을 이끌 것으로 예측됩니다. 스포츠 부상이란 스포츠나 신체 활동 중에 받는 상해나 외상을 말하며, 근육, 힘줄, 인대, 뼈, 관절 등에 영향을 미칩니다. 스포츠 부상과 관련된 건염의 치료는 일반적으로 손상된 건의 회복을 촉진하고, 붓기를 억제하고, 환부를 지원하기 위해 휴식, 통증 관리 및 물리치료를 결합합니다. 예를 들어, 2024년 7월 호주 정부 기관인 호주 보건 복지 연구소(Australian Institute of Health and Welfare)는 2022년 부상률이 가장 높았던 것은 야외 팀 스포츠로 참가자의 약 26%가 영향을 받았다고 보고했습니다. 컴뱃 스포츠는 16%의 부상률로 약간 차이가 있었고, 실내 팀 스포츠, 모터 스포츠, 승마 스포츠는 각각 약 15%의 참가자가 부상을 입었습니다. 따라서 스포츠 부상 증가 추세는 건염 치료 시장의 성장을 가속합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Tendonitis treatment involves methods aimed at reducing inflammation in the tissue that connects muscles and bones, known as tendons. The goal is to apply various therapies that restore strength and flexibility to the affected tendons, alleviating inflammation and pain in the affected area.

The primary types of tendonitis treatments include rest, hot and cold therapy, physical therapy, shockwave therapy, and surgical interventions. Therapeutic therapy encompasses a diverse range of processes focused on promoting healing and addressing specific issues. In tendonitis treatment, therapeutic therapy includes various interventions such as steroids, surgery, and physical therapies to diminish inflammation and alleviate pain. Common types of tendonitis conditions include tennis elbow, golfer's elbow, pitcher's elbow, jumper's knee, swimmer's shoulder, and Achilles tendonitis. These treatments are utilized across different end-users, including hospitals, specialty clinics, home healthcare, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The tendonitis treatment market research report is one of a series of new reports from The Business Research Company that provides tendonitis treatment market statistics, including tendonitis treatment industry global market size, regional shares, competitors with a tendonitis treatment market share, detailed tendonitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tendonitis treatment industry. This tendonitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tendonitis treatment market size has grown steadily in recent years. It will grow from $221.21 billion in 2024 to $228.07 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to pharmaceutical developments, increased sports injuries, aging population, occupational factors, awareness and education.

The tendonitis treatment market size is expected to see strong growth in the next few years. It will grow to $277.89 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to government support and funding, personalized medicine, expansion of regenerative therapies, rise in demand for non-invasive treatments, remote monitoring and telehealth. Major trends in the forecast period include research and development, regenerative therapies, advancements in physical therapy, focus on minimally invasive treatments, telemedicine for remote consultations.

The forecast of 5.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of ultrasound-guided corticosteroid injection kits sourced from Ireland and Japan, thereby delaying pain management and elevating orthopedic clinic costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing occurrence of sports injuries is anticipated to drive the growth of the tendonitis treatment market in the future. A sports injury refers to any injury or trauma sustained during sports or physical activities, affecting muscles, tendons, ligaments, bones, and joints. Treatment for tendonitis related to sports injuries typically involves a combination of rest, pain management, and physical therapy to promote recovery of the injured tendon, reduce swelling, and support the affected area. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that in 2022, the highest injury rate was found in outdoor team sports, impacting approximately 26% of participants. Combat sports followed closely with a 16% injury rate, while indoor team sports, motor sports, and equestrian sports each had around 15% of participants injured (ASC, 2023). Thus, the rising prevalence of sports injuries is fueling the growth of the tendonitis treatment market.

The rise in the global geriatric population is expected to contribute to the growth of the tendonitis treatment market. The geriatric population, typically aged 65 years or older, is witnessing an increasing incidence of tendonitis, necessitating advanced and effective treatment approaches tailored to address the specific needs of older individuals. As reported by the World Health Organization in October 2022, the global population of individuals aged 60 years is projected to reach 1.4 billion by 2030, compared to 1 billion in 2020. Moreover, it is estimated that 1 out of 6 people worldwide will be aged 60 years or older by 2030. Therefore, the growing global geriatric population is poised to drive the growth of the tendonitis treatment market.

Major companies in the tendonitis treatment market are concentrating on developing technologically advanced solutions, such as stem cell therapies, to enhance healing and shorten recovery times for patients. Stem cell therapies utilize stem cells to promote healing and repair damaged tissues in the body. These treatments harness the regenerative capabilities of stem cells to address various conditions, including tendonitis, by improving tissue regeneration and reducing inflammation. For example, in April 2022, C.H. Boehringer Sohn AG & Co. KG, a pharmaceutical company based in Germany, launched RenuTend to improve the healing of tendon and suspensory ligament injuries in horses. RenuTend is a targeted stem cell therapy designed to enhance tendon healing by promoting parallel fiber alignment and minimizing scar tissue formation, which is vital for preventing reinjury in horses. Administered through intralesional injection, this innovative treatment demonstrates proven efficacy and consistent results, representing a significant advancement in equine veterinary medicine.

Major players in the tendonitis treatment market are intensifying their focus on introducing innovative implants, such as bioinductive implants, to gain a competitive advantage. Bioinductive implants stimulate the body's natural healing processes by providing a scaffold that promotes tissue regeneration. In July 2023, Smith & Nephew plc launched the REGENETEN bioinductive implant in India for rotator cuff repair. This implant supports the body's natural healing response, facilitating new tendon-such as tissue growth and altering the course of rotator cuff disease. Comprised of type 1 collagen, the implant offers an advanced healing solution for biological tendon regeneration across the spectrum of rotator cuff disease. About the size of a postage stamp, the implant is delivered arthroscopically through a small incision and disappears within six months, inducing the growth of new tendon-such as tissue and collagen orientation indicative of functional loading.

In April 2023, Vander-Bend Manufacturing, Inc., a US-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. This acquisition is aimed at expanding Vander-Bend Manufacturing's manufacturing capabilities in the Northeast and Southwest. Omni Components Corporation is a US-based manufacturer and service provider of medical products specializing in spinal, cardiovascular, and tendon-related surgeries.

Major companies operating in the tendonitis treatment market include Merck & Co. Inc., Bayer AG, Boehringer Ingelheim GmbH, Abbott Laboratories, Pfizer Inc., Almatica Pharma Inc., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Ossur hf, Tynor India Ltd., Arthrex Inc., CONMED Corporation, TendoMed Inc., BioPro Inc., Aevumed Inc., Alafair Biosciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Wright Medical Group N.V., Breg Inc., Mueller Sports Medicine Inc., Bauerfeind AG, BSN medical GmbH, Henry Schein Inc.

North America was the largest region in the tendonitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global tendonitis treatment market report during the forecast period. The regions covered in the tendonitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tendonitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tendonitis treatment market includes revenues earned by entities by providing various treatment to relieve pain and reduce irritation in tendinitis such as pain relivers, steroids, platelet rich-plasma, dry needling, compression and elevation, bracing and splinting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tendonitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tendonitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for tendonitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tendonitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Tendonitis Treatment Market Characteristics

3. Tendonitis Treatment Market Trends And Strategies

4. Tendonitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tendonitis Treatment Growth Analysis And Strategic Analysis Framework

6. Tendonitis Treatment Market Segmentation

7. Tendonitis Treatment Market Regional And Country Analysis

8. Asia-Pacific Tendonitis Treatment Market

9. China Tendonitis Treatment Market

10. India Tendonitis Treatment Market

11. Japan Tendonitis Treatment Market

12. Australia Tendonitis Treatment Market

13. Indonesia Tendonitis Treatment Market

14. South Korea Tendonitis Treatment Market

15. Western Europe Tendonitis Treatment Market

16. UK Tendonitis Treatment Market

17. Germany Tendonitis Treatment Market

18. France Tendonitis Treatment Market

19. Italy Tendonitis Treatment Market

20. Spain Tendonitis Treatment Market

21. Eastern Europe Tendonitis Treatment Market

22. Russia Tendonitis Treatment Market

23. North America Tendonitis Treatment Market

24. USA Tendonitis Treatment Market

25. Canada Tendonitis Treatment Market

26. South America Tendonitis Treatment Market

27. Brazil Tendonitis Treatment Market

28. Middle East Tendonitis Treatment Market

29. Africa Tendonitis Treatment Market

30. Tendonitis Treatment Market Competitive Landscape And Company Profiles

31. Tendonitis Treatment Market Other Major And Innovative Companies

32. Global Tendonitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tendonitis Treatment Market

34. Recent Developments In The Tendonitis Treatment Market

35. Tendonitis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기